These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16003837)

  • 1. Osteonecrosis of the jaw and bisphosphonates.
    Woo SB; Hande K; Richardson PG
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16003837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonates and osteonecrosis of the jaw.
    Shenker NG; Jawad AS
    Rheumatology (Oxford); 2007 Jul; 46(7):1049-51. PubMed ID: 17500074
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteonecrosis of the jaw and bisphosphonates.
    Durie BG; Katz M; Crowley J
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16000365
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: a potential threat to your patients.
    Dreiman BB
    J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
    Jeffcoat M; Watts NB
    Gen Dent; 2008; 56(1):96-102; quiz 103-4, 111-2. PubMed ID: 18254568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
    Kraj M; Pogłód R; Maj S; Owczarska K
    Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
    [No Abstract]   [Full Text] [Related]  

  • 10. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
    Krishnan A; Arslanoglu A; Yildirm N; Silbergleit R; Aygun N
    J Comput Assist Tomogr; 2009; 33(2):298-304. PubMed ID: 19346864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on osteonecrosis of the jaws and bisphosphonates.
    Chehade MJ
    Climacteric; 2007 Oct; 10(5):440-1. PubMed ID: 17852148
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
    Olson KB; Hellie CM; Pienta KJ
    Urology; 2005 Sep; 66(3):658. PubMed ID: 16140106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The buzz about bisphosphonates.
    Farrar SK
    LDA J; 2005; 64(3):27. PubMed ID: 16639795
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating osteoporosis.
    Smith G; Stassen L; Flint S
    Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates and oral pathology I. General and preventive aspects.
    Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates and avascular necrosis of the jaws.
    Carter GD; Goss AN
    Aust Dent J; 2003 Dec; 48(4):268. PubMed ID: 14738134
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteonecrosis of the jaw--do bisphosphonates pose a risk?
    Bilezikian JP
    N Engl J Med; 2006 Nov; 355(22):2278-81. PubMed ID: 17135582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.